UW Medicine Resident Physician at Seattle Children’s Hospital Charged for Diverting Fentanyl
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • UW Medicine Resident Physician at Seattle Children’s Hospital Charged for Diverting Fentanyl

UW Medicine Resident Physician at Seattle Children’s Hospital Charged for Diverting Fentanyl

Julio 01, 2025
|
Share Article
|
Download Press Release
For Immediate Release
Contact:
Phone Number: (571) 387-3831

SEATTLE, Wash.--Dr. Andrew Voegel-Podadera, 35, a resident physician at the University of Washington Medical School who worked at Seattle Children’s Hospital, UW Medicine, and Harborview Medical Center is charged with two counts of Acquiring a Controlled Substance by Misrepresentation, Fraud, Deception, and Subterfuge.

On June 24th, 2025, DEA Seattle Diversion Group and DEA agents, along with the Food and Drug Administration - Office of Criminal Investigations,  arrested Voegel-Podadera at his residence and transported him to the Federal Courthouse for an initial hearing. 

As an anesthesia resident at the University of Washington and Seattle Children’s Hospital, Voegel-Podadera was found to have diverted Fentanyl, Remifentanil, Sufentanil, Hydromorphone and other controlled substances while treating children. In addition to practicing medicine while under the influence of controlled substance, Voegel-Podadera tampered with and diverted controlled substances that were ordered for three children. 

“Diverting medicine away from infant patients is despicable, doubly so if the person involved is a doctor,” said David F. Reames, Special Agent in Charge, DEA Seattle Field Division. “If Dr. Voegel-Podadera is convicted, it will show that he violated both his oath and the law, and I am proud that DEA could help stop him.”

According to the complaint, the attending physician at Seattle Children’s believed that Voegel-Podadera was displaying behavior consistent with drug use, including unexplained delays and absences from the operating room.   On December 27, 2024, as a resident anesthesiologist, he treated three minor patients The attending physician observed Voegel-Podadera draw up an excessive amount of fentanyl into syringes that would not be needed for their patients that day.  With concerns Voegel- Podadera was diverting, Seattle Children’s arranged for all the substances returned as wastage to be tested that day and found the waste syringes were filled with saline solution.

The DEA Seattle Diversion Group received a report Voegel-Podadera was suspected of diverting controlled substances in January 2025.  In February 2025,  the investigation revealed Voegel-Podadera allegedly diverted controlled substances while working at Seattle Children’s Hospital, as well as the University of Washington Medical Center, and Harborview Medical Center, going back to January 2024.

On June 12, 2025, DEA Diversion served Voegel-Podadera with an Immediate Suspension Order, suspending his controlled substance prescribing abilities. He was arrested on June 24th, 2025.

The charges contained in the criminal complaint are only allegations.  A person is presumed innocent unless and until he or she is proven guilty beyond a reasonable doubt in a court of law.

This operation took place as part of the 2025 Department of Justice National Health Care Fraud Enforcement Action.

###

 

Download Press Release
###
Fentanyl Hydromorphone
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

David F. Reames Special Agent in Charge - Seattle
@DEASeattleDiv
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster